vers la météo de la validation par utilisateur
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +----------------COMP:N-N(of)----------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (@card@,hour) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------SUBJ:V-N----------------------------------+ +------COMP:N-N(from)-----+ | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ | | | +--------------------COMP:N-N(of)--------------------+ | +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+ | | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) COMP:N-N(of) (dosage,hour) MOD_ATT:N-N (period,treatment) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ | +-------------COMP:N-N(of)------------+-COMP:N-N(of)-+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ +MOD_ATT:+ +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (dosage,period) MOD_ATT:N-N (period,treatment) COMP:N-N(of) (period,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-N+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ +------COMP:N-N(from)-----+ +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) COMP:N-N(from) (hepatocytes,__SP__) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +---MOD_ATT:N-N---+ +MOD_ATT:N-A+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-N (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-ADJ (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+-------------------------------------------------------COMP:V-N(In)------------------------------------------------------+ | +-----------------------------------------COMP:V-N(from)----------------------------------------+ | | +-----------------------------------SUBJ:V-N----------------------------------+ +-------COMP:N-N(of)-------+ +--MOD_ATT:N-ADJ--+ +MOD_ATT:N-N+ +-------------------APPOS-------------------+------COMP:N-N(of)-----+ | | +-MOD_ATT:N-ADJ+ | +MOD_ATT:N+ | +MOD_AT+ +MOD_ATT+ +COMP:N-+ | +MOD_AT+ +--OBJ:V-N-+ | +MOD_AT+ | | | | | | | | | | | | | | | | | | In primary culture hepatocytes from male adult __SP__ , clofibric acid ( with a dosage of 100 mcmolar and a treatment period of 48 96 hours ) increases expression of __SP__ __NODE__ mRNA . MOD_ATT:N-ADJ (hepatocytes,primary) MOD_ATT:N-N (hepatocytes,culture) MOD_ATT:N-N (__SP__,male) MOD_ATT:N-N (__SP__,adult) MOD_ATT:N-ADJ (acid,clofibric) APPOS (acid,treatment) COMP:N-N(of) (dosage,@card@) COMP:N-N(of) (treatment,hour) MOD_ATT:N-ADJ (hour,@card@) COMP:V-N(In) (increase,hepatocytes) COMP:V-N(from) (increase,__SP__) SUBJ:V-N (increase,acid) OBJ:V-N (increase,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)